Which medications in the drug class Topical Skin Products are used in the treatment of Cutaneous Squamous Cell Carcinoma?

Updated: Jul 08, 2020
  • Author: Talib Najjar, DMD, MDS, PhD; Chief Editor: Arlen D Meyers, MD, MBA  more...
  • Print

Topical Skin Products

The use of topical and photodynamic therapies is generally limited to actinic keratoses and in situ lesions.

Imiquimod (Aldara, Zyclara)

Imiquimod is approved by the FDA for the treatment of genital warts, actinic keratoses, and superficial basal cell carcinoma (BCC). This agent is an imidazoquinoline that enhances cell-mediated immune responses via the induction of proinflammatory cytokines; that is, it up-regulates interferon and other cytokines.

Diclofenac topical (Solaraze)

Diclofenac gel is approved by the FDA for the treatment of actinic keratoses. It is applied to lesion areas twice a day for 60-90 days.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!